Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ichikawa

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Inflammatory Intestinal Diseases|February 1, 2024
White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort StudyHiroki Kiyohara, Hajime Yamazaki, Kei Moriya, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Nature Communications|February 14, 2018
A secondary RET mutation in the activation loop conferring resistance to vandetanibTakashi Nakaoku, Takashi Kohno, Mitsugu Araki, et al.
Cancer Discovery|June 27, 2023
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II StudyTakafumi Koyama, Toshio Shimizu, Yuki Kojima, et al.
Plos One|June 26, 2015
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem CellsTakeshi Fujita, Fumiko Chiwaki, Ryou-u Takahashi, et al.
Frontiers in Oncology|December 13, 2021
Clinical Utility of Circulating Tumor DNA in Advanced Rare CancersHitomi Sumiyoshi Okuma, Kan Yonemori, Yuki Kojima, et al.
Journal of the Endocrine Society|December 22, 2017
An Excess of CYP24A1, Lack of CaSR, and a Novel lncRNA Near the PTH Gene Characterize an Ectopic PTH-Producing TumorKosuke Uchida, Yuji Tanaka, Hitoshi Ichikawa, et al.
Gynecologic Oncology Reports|December 6, 2023
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinomaYuki Kojima, Hiroshi Yoshida, Toshihiro Okuya, et al.
BJC Reports|November 8, 2024
Predictive and prognostic value of excision repair cross-complementing group 1 in patients with advanced gastric cancerYasuhide Yamada, Kengo Nagashima, Mizutomo Azuma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2021
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Yukiko Shimoda, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Inflammatory Intestinal Diseases|February 1, 2024
White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort StudyHiroki Kiyohara, Hajime Yamazaki, Kei Moriya, et al.
Breast Cancer Research and Treatment|December 9, 2022
Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancerAkihiko Shimomura, Masayuki Yoshida, Takashi Kubo, et al.
Nature Communications|February 14, 2018
A secondary RET mutation in the activation loop conferring resistance to vandetanibTakashi Nakaoku, Takashi Kohno, Mitsugu Araki, et al.
Cancer Discovery|June 27, 2023
Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II StudyTakafumi Koyama, Toshio Shimizu, Yuki Kojima, et al.
Plos One|June 26, 2015
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem CellsTakeshi Fujita, Fumiko Chiwaki, Ryou-u Takahashi, et al.
Frontiers in Oncology|December 13, 2021
Clinical Utility of Circulating Tumor DNA in Advanced Rare CancersHitomi Sumiyoshi Okuma, Kan Yonemori, Yuki Kojima, et al.
Journal of the Endocrine Society|December 22, 2017
An Excess of CYP24A1, Lack of CaSR, and a Novel lncRNA Near the PTH Gene Characterize an Ectopic PTH-Producing TumorKosuke Uchida, Yuji Tanaka, Hitoshi Ichikawa, et al.
Gynecologic Oncology Reports|December 6, 2023
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinomaYuki Kojima, Hiroshi Yoshida, Toshihiro Okuya, et al.
BJC Reports|November 8, 2024
Predictive and prognostic value of excision repair cross-complementing group 1 in patients with advanced gastric cancerYasuhide Yamada, Kengo Nagashima, Mizutomo Azuma, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2021
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLCMasayuki Shirasawa, Tatsuya Yoshida, Yukiko Shimoda, et al.
Pageof 17